Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Overview and Scope
Dumping syndrome, also known as rapid gastric emptying, is a medical condition when the stomach empties its contents too quickly into the small intestine, often leading to uncomfortable and sometimes severe symptoms. It usually occurs after certain stomach surgeries, particularly gastric bypass or partial gastrectomy.

Sizing and Forecast
The dumping syndrome market size has grown rapidly in recent years. It will grow from $1.12 billion in 2023 to $1.24 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%.  The  growth in the historic period can be attributed to gastric surgery procedures, increased prevalence of obesity, advancements in surgical techniques, improved diagnostic methods.

The dumping syndrome market size is expected to see strong growth in the next few years. It will grow to $1.81 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%.  The growth in the forecast period can be attributed to weight loss surgery trends, personalized treatment approaches, nutritional and dietary interventions, telemedicine and remote monitoring. Major trends in the forecast period include minimally invasive surgical techniques, data analytics and ai, increased collaboration, preventive measures.

To access more details regarding this report, visit the link:

Segmentation & Regional Insights
The dumping syndrome market covered in this report is segmented –

1) By Diagnosis: Blood Sugar Test; Gastric Emptying Test; Medical History; Other Diagnosis
2) By Treatment: Medication; Surgery; Other Treatments
3) By Route Of Administration: Oral; Intravenous; Other Routes Of Administration
4) By Phase: Early Dumping Phase; Late Dumping Phase
5) By End User: Hospitals And Clinics; Research Laboratories; Other End Users

North America was the largest region in the dumping syndrome market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dumping syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

Major Driver Impacting Market Growth
The rising prevalence of upper GI diseases is expected to propel the growth of the dumping syndrome market going forward. Upper gastrointestinal (GI) diseases refer to disorders affecting the upper part of the digestive system, including the esophagus, stomach and the first part of the small intestine (duodenum). Dumping syndrome is a condition that can occur after a person undergoes particular upper gastrointestinal (GI) surgeries, particularly those that involve the stomach, duodenum, or pyloric sphincter. For instance, in April 2023, according to the National Library of Medicine, a US-based medical library, Upper gastrointestinal bleeding (UGIB) is a frequent issue, with an estimated occurrence in 80 to 150 out of 100,000 individuals annually. The estimated mortality rates range from 2 to 15 percent. Upper gastrointestinal bleeding (UGIB) constitutes 75% of all cases of acute gastrointestinal (GI) bleeding. Therefore, the rising prevalence of upper GI diseases is driving the growth of the dumping syndrome market.

Key Industry Players
Major players in the dumping syndrome market are  Cardinal Health Inc., Johnson & Johnson Private Limited, Abbott Laboratories Inc., Medtronic PLC, Covidien PLC, Fujifilm Holdings Corporation, Stryker Corporation, Allergan PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Terumo Corporation, Steris Corporation, Teleflex Medical Europe Ltd., Cook Medical Inc., Karl Storz SE & Co. KG, Conmed Corporation, Applied Medical Resources Corporation, Richard Wolf GmbH, Pentax Medical Company, GI Dynamics, EndoGastric Solutions Inc., Apollo Endosurgery Inc., EndoChoice Holdings Inc., Cousin Biotech , Mediflex Surgical Product, Asensus Surgical Inc., USGI Medical Inc., TransEnterix Inc.

The dumping syndrome market report table of contents includes:

1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis


Related Reports:



Explore the trending research reports from TBRC:

Contact Us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model


Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe